Clinical Enzymology/fxn If Covered Flashcards
Creatine kinase
Ck-MB (ck2)- MI marker. Early, peaks 24 hrs, gone after 48 hrs
Ck-MM (ck3)-rhapdomyolysis (I.e: mcardle gsd 5 myophosphorylase)
MI markers
Ck-MB and total CK (CK-MB >3-5% depending on other test). Early marker
cTnI and cTnT (not TnC) early marker. Lasts several days
LDH- late marker LDH1>LDH2 (switch)
Myoglobin (unspecific early marker)
LDH
In MI LDH1>LDH2. Peaks @ 48, observable at 24 hrs. Half life 5 days.
Reversible: pyruvate to lactate, nad+ to nadh
Alanine amino transferase
ALT, marker for liver damage
EtOH abuse->cirrhosis AST/ALT >2
Alanine and a-Kg to pyruvate and glutamate
Use ala as substrate for gluconeogenesis.
Aspartate aminotransferase
Liver damage marker
AST
EtOH abuse->cirrhosis AST/ALT >2
Liver damage
AST, alt, ammonium, bilirubin, albumin
EtOH abuse->cirrhosis AST/ALT >2
Biliary system
Alkaline phosphotase (liver isozyme), GGT (gamma glutamyl transpeptidase)
Alkaline phosphotase
Biliary obstruction w/ GGT (ALP-1)
Bone (alone) (ALP-2)
Gamma-glutamyltranspeptidase (transferase)
Makes GSH
Biliary obstruction marker with ALP
Increased in response to EtOH or other medications
EtOH abuse
AST/ALT >2
High GGT
Lipase/Amylase >2
Pancreatitis
a-amylase, pancreatic lipase
Acute: gallstones, heavy ETOH intake (lipase/amylase>2)
Chronic: CF, hypertriglycerolemia, years of alcoholism.
Bones
ALP-2 (made by osteoblasts)
Bone disease or tumors
High levels normal in growing children and pregnancy.
Prostate cancer
PSA
a-fetoprotein (AFP)
Hepatocellular, testicular, ovarian tumors